Mereo BioPharma Group plc - Sponsored ADR (MREO) vs Nomad Power Solutions, Inc. (NMAD)

Mereo BioPharma Group plc - Sponsored ADR and Nomad Power Solutions, Inc. are both Biotechnology companies. Mereo BioPharma Group plc - Sponsored ADR and Nomad Power Solutions, Inc. are of similar size ($58.5M and $54.9M). Across the 9 metrics below, Nomad Power Solutions, Inc. leads on 6 and Mereo BioPharma Group plc - Sponsored ADR on 3.

Valuation

Metric MREO NMAD Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 2.08 1.93 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (47.19%) (27.93%) (28.84%)
Free cash flow yield (43.16%) (11.31%) (23.03%)

Profitability

Metric MREO NMAD Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (67.85%) (68.04%) (57.72%)
Return on assets (57.73%) (62.67%) (49.22%)
Return on invested capital 0.00% (40.41%) 0.00%

Growth

Metric MREO NMAD Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 10.16% 20.75% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MREO NMAD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.88 12.87 4.73
Net debt to EBITDA 1.04 1.00 0.96

Dividend

Metric MREO NMAD Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric MREO NMAD Biotechnology median
Market cap 54.88m 58.45m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack